Safety signals for QT prolongation or Torsades de Pointes associated with azithromycin with or without chloroquine or hydroxychloroquine

Amir Sarayani, Brian Cicali, Carl H Henriksen, Joshua D Brown

Research in Social and Administrative Pharmacy, vol. 17, Elsevier, 2021, pp. 483--486

Antihypertensive drugs and risk of COVID-19?

Joshua D Brown

The Lancet. Respiratory Medicine, vol. 8, Elsevier, 2020, pp. e28

Cannabidiol as prophylaxis for SARS-CoV-2 and COVID-19? Unfounded claims versus potential risks of medications during the pandemic.

Joshua D Brown

Research in social \& administrative pharmacy: RSAP, 2020

Potential adverse drug events and drug--drug interactions with medical and consumer cannabidiol (CBD) use

Joshua D Brown, Almut G Winterstein

Journal of clinical medicine, vol. 8, Multidisciplinary Digital Publishing Institute, 2019, p. 989

Effectiveness and safety of apixaban versus rivaroxaban for prevention of recurrent venous thromboembolism and adverse bleeding events in patients with venous thromboembolism: a retrospective population-based cohort analysis

Ghadeer K Dawwas, Joshua Brown, Eric Dietrich, Haesuk Park

The Lancet Haematology, vol. 6, Elsevier, 2019, pp. e20--e28

Mass casualty shooting venues, types of firearms, and age of perpetrators in the United States, 1982--2018

Joshua D Brown, Amie J Goodin

American journal of public health, vol. 108, American Public Health Association, 2018, pp. 1385--1387

Risk stratification for bleeding complications in patients with venous thromboembolism: application of the HAS-BLED bleeding score during the first 6 months of anticoagulant treatment

Joshua D Brown, Amie J Goodin, Gregory YH Lip, Val R Adams

Journal of the American Heart Association, vol. 7, 2018, pp. e007901

Rural and Appalachian disparities in neonatal abstinence syndrome incidence and access to opioid abuse treatment

Joshua D Brown, Amie J Goodin, Jeffery C Talbert

The Journal of rural health, vol. 34, 2018, pp. 6--13

The relative burden of community-acquired pneumonia hospitalizations in older adults: a retrospective observational study in the United States

Joshua D Brown, James Harnett, Richard Chambers, Reiko Sato

BMC geriatrics, vol. 18, BioMed Central, 2018, p. 92

Relative clinical and cost burden of community-acquired pneumonia hospitalizations in older adults in the United States—a cross-sectional analysis

Omotola Olasupo, Hong Xiao, Joshua D Brown

Vaccines, vol. 6, Multidisciplinary Digital Publishing Institute, 2018, p. 59

Vena cava filter retrieval rates and factors associated with retrieval in a large US cohort

Joshua D Brown, Driss Raissi, Qiong Han, Val R Adams, Jeffery C Talbert

Journal of the American Heart Association, vol. 6, 2017, pp. e006708

Adherence to rivaroxaban, dabigatran, and apixaban for stroke prevention for newly diagnosed and treatment-naive atrial fibrillation patients: an update using 2013-2014 data

Joshua D Brown, Anand R Shewale, Jeffery C Talbert

Journal of managed care \& specialty pharmacy, vol. 23, Academy of Managed Care Pharmacy, 2017, pp. 958--967

Rates of neonatal abstinence syndrome amid efforts to combat the opioid abuse epidemic

Joshua D Brown, Pratik A Doshi, Nathan J Pauly, Jeffery C Talbert

JAMA pediatrics, vol. 170, American Medical Association, 2016, pp. 1110--1112

Predictive validity of the beers and screening tool of older persons’ potentially inappropriate prescriptions (STOPP) criteria to detect adverse drug events, hospitalizations, and emergency department visits in the United States

Joshua D Brown, Lisa C Hutchison, Chenghui Li, Jacob T Painter, Bradley C Martin

Journal of the American Geriatrics Society, vol. 64, 2016, pp. 22--30

A comparison of oral anticoagulant use for atrial fibrillation in the pre-and post-DOAC eras

Joshua D Brown, Anand R Shewale, Parinita Dherange, Jeffery C Talbert

Drugs \& aging, vol. 33, Springer International Publishing, 2016, pp. 427--436

Adherence to rivaroxaban, dabigatran, and apixaban for stroke prevention in incident, treatment-na\"\ive nonvalvular atrial fibrillation

Joshua D Brown, Anand R Shewale, Jeffery C Talbert

Journal of managed care \& specialty pharmacy, vol. 22, Academy of Managed Care Pharmacy, 2016, pp. 1319--1329

Low-cost generic program use by Medicare beneficiaries: implications for medication exposure misclassification in administrative claims data

Nathan J Pauly, Jeffery C Talbert, Joshua Brown

Journal of managed care \& specialty pharmacy, vol. 22, Academy of Managed Care Pharmacy, 2016, pp. 741--751

Prevalence of Low-Cost Generic Program Use in a Nationally Representative Cohort of Privately Insured Adults

Nathan J Pauly, Joshua D Brown

Journal of Managed Care and Specialty Pharmacy: JMCP, vol. 21, Academy of Managed Care Pharmacy, 2015, pp. 1162--1170

Development of high-throughput HILIC-MS/MS methodology for plasma citrulline determination in multiple species

Prem K Gupta, Joshua Brown, Prabath G Biju, John Thaden, Nicolaas E Deutz, Sree Kumar, Martin Hauer-Jensen, Howard P Hendrickson

Analytical Methods, vol. 3, Royal Society of Chemistry, 2011, pp. 1759--1768